Centene Corp (CNC)
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
- Ticker
- CNC
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Market cap
- $34.52B
- 52-week range
- $31.63 - $78.08
Valuation
- Share price
- $69.74 (close of Nov 6, 2026)
- P/E (TTM)
- 22.94x
- Price to book
- 1.55x
- Price to free cash flow
- 8.75x
- Enterprise value
- $26.48B
- Book value per share
- $45.02
Price performance
| Period | Change |
|---|---|
| 1 day | -5.97% |
| 5 days | +1.88% |
| 1 month | +7.94% |
| 3 months | +8.63% |
| 6 months | +26.04% |
| Year to date | +69.48% |
| 1 year | +87.98% |
| 3 years | -2.92% |
| 5 years | -5.97% |
| 10 years | +126.36% |
| All time | +4,765.58% |
Short interest
- As of
- Oct 15, 2026
- Short % of float
- 2.53%
- Shares short
- 10.93M
- Days to cover
- 2.53
- Change since prior report
- +4.01%
- Source
- FINRA consolidated short interest
Members of Congress who disclosed CNC trades
Tim Moore · Gilbert Ray Cisneros · Jefferson Shreve · Julia Letlow · Robert Bresnahan · Val Hoyle
Super investors holding CNC
Bill Nygren (Harris Associates LP) · David Einhorn (DME Capital Management) · Ken Griffin (Citadel) · Ray Dalio (Bridgewater Associates) · Tweedy Browne (Tweedy Browne Company LLC)
Profitability and growth
- Return on equity
- -33.32%
- Return on assets
- -8.70%
- Net margin
- -3.43%
- Revenue growth
- 19.44%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 11.42%
- Current ratio
- 1.16x
- Net debt to EBITDA
- -2.13x
Latest reported year
- Period end
- Dec 31, 2025
- Fiscal year
- 2025
- Revenue
- $194.78B
- Net income
- -$6.67B
- Earnings per share
- $-13.53
- Interest expense
- $678.00M
- Shares outstanding
- 493.12M
Income statement by year
| Period end | Revenue | Net income | EPS |
|---|---|---|---|
| 2025-12-31 | $194.78B | -$6.67B | -$13.53 |
| 2024-12-31 | $163.07B | $3.31B | $6.33 |
| 2023-12-31 | $154.00B | $2.70B | $4.97 |
| 2022-12-31 | $144.55B | $1.20B | $2.09 |
| 2021-12-31 | $125.98B | $1.35B | $2.31 |
| 2020-12-31 | $111.11B | $1.81B | $3.17 |
| 2019-12-31 | $74.64B | $1.32B | $3.19 |
| 2018-12-31 | $60.12B | $900.00M | $2.31 |
| 2017-12-31 | $48.38B | $828.00M | $2.40 |
| 2016-12-31 | $40.61B | $562.00M | $1.76 |
Margins and returns by year
| Period end | Net margin | Return on equity |
|---|---|---|
| 2025-12-31 | -3.43% | -33.32% |
| 2024-12-31 | 2.03% | 12.47% |
| 2023-12-31 | 1.75% | 10.42% |
| 2022-12-31 | 0.83% | 4.97% |
| 2021-12-31 | 1.07% | 5.00% |
| 2020-12-31 | 1.63% | 6.98% |
| 2019-12-31 | 1.77% | 10.44% |
| 2018-12-31 | 1.50% | 8.17% |
| 2017-12-31 | 1.71% | 12.06% |
| 2016-12-31 | 1.38% | 9.51% |
Cash and debt by year
| Period end | Cash | Debt |
|---|---|---|
| 2025-12-31 | $20.32B | $17.35B |
| 2024-12-31 | $16.68B | $18.42B |
| 2023-12-31 | $19.65B | $17.71B |
| 2022-12-31 | $14.39B | $17.94B |
| 2021-12-31 | $14.66B | $18.57B |
| 2020-12-31 | $12.38B | $16.68B |
| 2019-12-31 | $12.99B | $13.64B |
| 2018-12-31 | $6.06B | $6.65B |
| 2017-12-31 | $4.60B | $4.70B |
| 2016-12-31 | $4.43B | $4.65B |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|---|---|
| 2025-12-31 | $4.32B | $204.00M |
| 2024-12-31 | -$490.00M | $212.00M |
| 2023-12-31 | $7.25B | $216.00M |
| 2022-12-31 | $5.26B | $234.00M |
| 2021-12-31 | $3.29B | $203.00M |
| 2020-12-31 | $4.63B | $281.00M |
| 2019-12-31 | $753.00M | $177.00M |
| 2018-12-31 | $559.00M | $145.00M |
| 2017-12-31 | $1.07B | $135.00M |
| 2016-12-31 | $1.54B | $148.00M |
Investor relations
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|---|---|
| 2026-10-27 | Sep 2026 | $0.07 |
| 2026-07-28 | Jun 2026 | $0.89 |
| 2026-04-28 | Mar 2026 | $1.87 |
| 2026-02-06 | Dec 2025 | -$1.25 |
| 2025-10-29 | Sep 2025 | -$0.21 |
| 2025-07-25 | Jun 2025 | $0.68 |
| 2025-04-25 | Mar 2025 | $2.36 |
| 2025-02-04 | Dec 2024 | $0.49 |
Filings and sources
- Company website
- centene.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Molina Healthcare, Inc. (MOH) · Humana Inc (HUM) · Cigna Group (CI) · Elevance Health, Inc. (ELV) · CVS Health Corp (CVS) · UnitedHealth Group Inc (UNH) · Veeva Systems Inc (VEEV) · HealthEquity, Inc. (HQY)
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades